The biochemist's outlook on cancer research.
D000332:Aerobiosis; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001671:Biochemistry / Q000266:history*; D002250:Carbon Radioisotopes; D002471:Cell Transformation, Neoplastic; D004261:DNA Replication / Q000187:drug effects; D004739:England; D005492:Folic Acid / Q000494:pharmacology; D005493:Folic Acid Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006019:Glycolysis; D049673:History, 20th Century; D006801:Humans; D007553:Isotope Labeling; D007773:Lactates / Q000378:metabolism; D007938:Leukemia / Q000188:drug therapy; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D012106:Research / Q000266:history*; D013763:Tetrahydrofolates / Q000494:pharmacology; D013936:Thymidine; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors; D013941:Thymine / Q000378:metabolism; D014481:United States
D000970:Antineoplastic Agents; D002250:Carbon Radioisotopes; D005493:Folic Acid Antagonists; D007773:Lactates; D013763:Tetrahydrofolates; D005492:Folic Acid; D013940:Thymidylate Synthase; D013941:Thymine; D013936:Thymidine